p-medicine

p-medicine

Medicine is undergoing a revolution that is transforming the nature of healthcare from reactive to preventive. The changes are catalyzed by a new systems approach to disease which focuses on integrated diagnosis, treatment and prevention of disease in individuals. This will replace our current mode of medicine over the coming years with a personalized predictive treatment. While the goal is clear, the path is fraught with challenges. P-medicine brings together international leaders in their fields to create an infrastructure that will facilitate this translation from current practice to personalized medicine. In achieving this objective p-medicine has formulated a coherent, integrated work plan for the design, development, integration and validation of technologically challenging areas of today. Our emphasis is on formulating an open, modular framework of tools and services, so that p-medicine can be adopted gradually, including efficient secure sharing and handling of large personalized data sets, enabling demanding Virtual Physiological Human (VPH) multi-scale simulations (in silico oncology), building standards-compliant tools and models for VPH research, drawing on the VPH Toolkit and providing tools for large-scale, privacy-preserving data and literature mining, a key component of VPH research. We will ensure that privacy, non-discrimination, and access policies are aligned to maximize protection of and benefit to patients. The p-medicine tools and technologies will be validated within the concrete setting of advanced clinical research. Pilot cancer trials have been selected based on clear research objectives, emphasising the need to integrate multilevel datasets, in the domains of Wilms tumour, breast cancer and leukaemia. To sustain a self-supporting infrastructure realistic use cases will be built that will demonstrate tangible results for clinicians. The project is clinically driven and promotes the principle of open source and open standards.

For further information, please visit:
http://www.p-medicine.eu

Project co-ordinator:
Universität des Saarlandes

Partners:

  • CUSTODIX NV
  • THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
  • SWISS INSTITUTE OF BIOINFORMATICS
  • ECANCERMEDICALSCIENCE AG
  • NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
  • INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
  • A. PERSIDIS & SIA OE
  • GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER
  • HEINRICH-HEINE-UNIVERSITAET DUESSELDORF
  • UNIVERSIDAD POLITECNICA DE MADRID
  • IBM ISRAEL - SCIENCE AND TECHNOLOGY LTD
  • FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
  • FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V
  • PHILIPS ELECTRONICS NEDERLAND B.V.
  • UNIVERSITY COLLEGE LONDON
  • EUROPEAN RESEARCH AND PROJECT OFFICE GMBH
  • CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
  • INSTYTUT CHEMII BIOORGANICZNEJ PAN
  • ISTITUTO EUROPEO DI ONCOLOGIA SRL

Timetable: from 01/2011 to 01/2015

Total cost: € 18.480.000

EC funding: € 13.330.000

Programme Acronym: FP7-ICT

Subprogramme Area: ICT-2009.5.3 Virtual Physiological Human

Contract type: Collaborative project (generic)

Related news articles:

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

Improved Cough-Detection Tech can Help w…

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...

Latest Business News

Latest Research News

Latest Conferences News

Latest Jobs